Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations

被引:2
作者
Barsotti, Anthony M. [1 ,2 ]
Ryskin, Michael [1 ]
Rollins, Robert A. [1 ]
机构
[1] Pfizer Worldwide Res & Dev, Oncol Res Unit, Pearl River, NY 10965 USA
[2] Kadmon Pharmaceut, New York, NY 10016 USA
关键词
epigenetic reprogramming; epigenetic therapy; EZH2; gain-of-function mutations; histone methylation; melanoma; polycomb; B-CELL LYMPHOMAS; LYSINE; 27; MELANOMA; CANCER; HYPERTRIMETHYLATION; INHIBITION; EXPRESSION; LANDSCAPE; PROTEINS; TARGET;
D O I
10.2217/epi.15.27
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:687 / 690
页数:4
相关论文
共 50 条
[31]   HDAC1,2 inhibition impairs EZH2-and BBAP- mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma [J].
Johnson, Danielle P. ;
Spitz, Gabriella S. ;
Tharkar, Shweta ;
Quayle, Steven N. ;
Shearstone, Jeffrey R. ;
Jones, Simon ;
McDowell, Maria E. ;
Wellman, Hannah ;
Tyler, Jessica K. ;
Cairns, Bradley R. ;
Chandrasekharan, Mahesh B. ;
Bhaskara, Srividya .
ONCOTARGET, 2015, 6 (07) :4863-4887
[32]   Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming [J].
Tang, Yawen ;
Zhao, Lianzhong ;
Yu, Xufen ;
Zhang, Jianyi ;
Qian, Li ;
Jin, Jian ;
Lu, Rui ;
Zhou, Yang .
STEM CELL RESEARCH, 2021, 53
[33]   Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential [J].
Sun, Ranran ;
Shen, Jacson ;
Gao, Yan ;
Zhou, Yubing ;
Yu, Zujiang ;
Hornicek, Francis ;
Kan, Quancheng ;
Duan, Zhenfeng .
ONCOTARGET, 2016, 7 (25) :38333-38346
[34]   Morphoproteomics Identifies SIRT1, EZH2 and CXCR4 Pathways in Diffuse Large B-Cell Lymphoma: Therapeutic Implications [J].
Brown, Robert E. ;
Zhang, Songlin ;
Wang, Xiaohong I. .
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (01) :27-32
[35]   Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma [J].
Park, Sungryul ;
Jo, Seung-Hyun ;
Kim, Jong-Hwan ;
Kim, Seon-Young ;
Ha, Jae Du ;
Hwang, Jong Yeon ;
Lee, Myeong Youl ;
Kang, Jong Soon ;
Han, Tae-Su ;
Park, Sung Goo ;
Kim, Sunhong ;
Park, Byoung Chul ;
Kim, Jeong-Hoon .
CANCERS, 2020, 12 (09) :1-22
[36]   Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes [J].
Zhao, Yongxu ;
Feng, Zhuanghui ;
Zhang, Yongxian ;
Sun, Yingmin ;
Chen, Yanhao ;
Liu, Xiaojian ;
Li, Shuang ;
Zhou, Tingting ;
Chen, Lanlan ;
Wei, Yuda ;
Ma, Danjun ;
Lui, Kathy O. ;
Ying, Hao ;
Chen, Yan ;
Ding, Qiurong .
CELL REPORTS, 2019, 26 (04) :884-+
[37]   Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis [J].
Trenkmann, Michelle ;
Brock, Matthias ;
Gay, Renate E. ;
Kolling, Christoph ;
Speich, Rudolf ;
Michel, Beat A. ;
Gay, Steffen ;
Huber, Lars C. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08) :1482-1488
[38]   De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy [J].
Syrbe, Steffen ;
Hedrich, Ulrike B. S. ;
Riesch, Erik ;
Djemie, Tania ;
Mueller, Stephan ;
Moller, Rikke S. ;
Maher, Bridget ;
Hernandez-Hernandez, Laura ;
Synofzik, Matthis ;
Caglayan, Hande S. ;
Arslan, Mutluay ;
Serratosa, Jose M. ;
Nothnagel, Michael ;
May, Patrick ;
Krause, Roland ;
Loeffler, Heidrun ;
Detert, Katja ;
Dorn, Thomas ;
Vogt, Heinrich ;
Kraemer, Guenter ;
Schoels, Ludger ;
Mullis, Primus E. ;
Linnankivi, Tarja ;
Lehesjoki, Anna-Elina ;
Sterbova, Katalin ;
Craiu, Dana C. ;
Hoffman-Zacharska, Dorota ;
Korff, Christian M. ;
Weber, Yvonne G. ;
Steinlin, Maja ;
Gallati, Sabina ;
Bertsche, Astrid ;
Bernhard, Matthias K. ;
Merkenschlager, Andreas ;
Kiess, Wieland ;
Gonzalez, Michael ;
Zuechner, Stephan ;
Palotie, Aarno ;
Suls, Arvid ;
De Jonghe, Peter ;
Helbig, Ingo ;
Biskup, Saskia ;
Wolff, Markus ;
Maljevic, Snezana ;
Schule, Rebecca ;
Sisodiya, Sanjay M. ;
Weckhuysen, Sarah ;
Lerche, Holger ;
Lemke, Johannes R. ;
Balling, Rudi .
NATURE GENETICS, 2015, 47 (04) :393-+
[39]   Gain-of-function mutations in beet DODA2 identify key residues for betalain pigment evolution [J].
Bean, Alexander ;
Sunnadeniya, Rasika ;
Akhavan, Neda ;
Campbell, Annabelle ;
Brown, Matthew ;
Lloyd, Alan .
NEW PHYTOLOGIST, 2018, 219 (01) :287-296
[40]   Targeting ERBB2 mutations in solid tumors: biological and clinical implications [J].
Cousin, Sophie ;
Khalifa, Emmanuel ;
Crombe, Amandine ;
Laizet, Yech'an ;
Lucchesi, Carlo ;
Toulmonde, Maud ;
Le Moulec, Sylvestre ;
Auzanneau, Celine ;
Soubeyran, Isabelle ;
Italiano, Antoine .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11